A Five Period, Open Label, Placebo Controlled Study to evaluate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of a Single Ascending Dose of IN-105 under Fed Conditions in T2DM subjects.
Phase of Trial: Phase II
Latest Information Update: 01 Sep 2016
At a glance
- Drugs Insulin tregopil (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 12 Mar 2013 Planned number of patients changed from 0 to 20 as reported by Clinical Trials Registry - India record.
- 09 Feb 2010 New trial record